Related Experiment Video
Updated: Jul 1, 2026

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
Published on: April 3, 2026
Polo-like kinase 1 is essential for early embryonic development and tumor suppression
Lin-Yu Lu1, Jamie L Wood, Katherine Minter-Dykhouse
1Division of Molecular Medicine and Genetics, Department of Internal Medicine, University of Michigan Medical School, 109 Zina Pitcher Place, BSRB 1520, Ann Arbor, MI 48109, USA.
Abstract:
Polo-like kinases (Plks) are serine/threonine kinases that are highly conserved in organisms from yeasts to humans. Previous reports have shown that Plk1 is critical for all stages of mitosis and may play a role in DNA replication during S phase. While much work has focused on Plk1, little is known about the physiological function of Plk1 in vivo. To address this question, we generated Plk1 knockout mice. Plk1 homozygous null mice were embryonic lethal, and early Plk1(-/-) embryos failed to survive after the eight-cell stage. Immunocytochemistry studies revealed that Plk1-null embryos were arrested outside the mitotic phase, suggesting that Plk1 is important for proper cell cycle progression. It has been postulated that Plk1 is a potential oncogene, due to its overexpression in a variety of tumors and tumor cell lines. While the Plk1 heterozygotes were healthy at birth, the incidence of tumors in these animals was threefold greater than that in their wild-type counterparts, demonstrating that the loss of one Plk1 allele accelerates tumor formation. Collectively, our data support that Plk1 is important for early embryonic development and may function as a haploinsufficient tumor suppressor.
Insights
Polo-like kinase 1 (Plk1) is essential for embryonic development, with null mice dying early. Loss of one Plk1 gene copy accelerates tumor formation, suggesting Plk1 acts as a tumor suppressor.
Area of Science:
- Cell Biology
- Molecular Biology
- Genetics
Background:
- Polo-like kinases (Plks) are conserved serine/threonine kinases crucial for cell division.
- Plk1 is known to be vital for mitosis, but its in vivo physiological functions remain largely uncharacterized.
- Overexpression of Plk1 in tumors suggests a potential role as an oncogene.
Purpose of the Study:
- To investigate the in vivo physiological function of Plk1.
- To determine the role of Plk1 in embryonic development and tumor suppression.
Main Methods:
- Generation of Plk1 knockout mouse models (homozygous and heterozygous).
- Analysis of embryonic lethality and cell cycle progression in Plk1-null embryos using immunocytochemistry.
- Assessment of tumor incidence in Plk1 heterozygous mice compared to wild-type controls.
Main Results:
- Plk1 homozygous null mice exhibited embryonic lethality, failing to survive past the eight-cell stage.
- Plk1-null embryos showed cell cycle arrest outside of mitosis, indicating a critical role in cell cycle progression.
- Plk1 heterozygous mice had a threefold higher incidence of tumors than wild-type mice, suggesting haploinsufficiency.
Conclusions:
- Plk1 is essential for early embryonic development and proper cell cycle progression.
- Plk1 acts as a haploinsufficient tumor suppressor, as loss of one allele accelerates tumor formation.
- These findings highlight Plk1's dual role in development and tumor suppression.
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
